Prognostic Value of Phase Angle in Systemic Immunoglobulin Light-chain (AL) Amyloidosis

Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Malnutrition is a prominent clinical feature of patients affected by systemic immunoglobulin light-chain amyloidosis (AL), with a prevalence ranging between 25-50%. Although the prognosis predominantly depend on the presence and severity of cardiac involvement, it was shown that malnutrition is an independent predictor of survival and quality of life. However, the assessment of nutritional status by common indices based on anthropometry is not always feasible and accurate due to reduced performance status and/or the presence of fluid imbalances (for example edema and ascites). Several recent studies have demonstrated the prognostic value of the phase angle. Moreover, the value is supported by its applicability to patients who are bedridden or present alterations in the state of hydration.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Diagnosis of systemic immunoglobulin light-chain (AL) amyloidosis

• Written informed consent

Locations
Other Locations
Italy
Fondazione IRCCS Policlinico San Matteo
Pavia
Time Frame
Start Date: 2014-02
Completion Date: 2019-04
Participants
Target number of participants: 127
Treatments
Amyloidosis
Consecutive adult patients affected by systemic immunoglobulin light-chain (AL) amyloidosis
Related Therapeutic Areas
Sponsors
Collaborators: Akern Srl
Leads: Fondazione IRCCS Policlinico San Matteo di Pavia

This content was sourced from clinicaltrials.gov